Model Number OPTIFLUX 180NR DIALYZER FINISHED ASSMBLY |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Reaction (2414)
|
Event Date 09/06/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
The plant investigation is in process.
A supplemental mdr will be submitted upon completion of this activity.
.
|
|
Event Description
|
A user facility clinical manager reported a patient who broke out in hives for an unspecified number of hemodialysis treatments occurring after (b)(6) 2018 while using fresenius optiflux dialyzers.
The clinic manager confirmed the patient had been administered 12.
5mg of benadryl intravenously, and remained on the machine to complete treatment, after which their symptoms resolved.
The clinic manager advised the patient had not missed any of their scheduled hemodialysis treatments due to the issue.
Due diligence attempts were exhausted, but additional patient and device information was not provided.
|
|
Manufacturer Narrative
|
Additional information: event description updated.
Brand name updated.
Medical device -model # and catalog # updated.
|
|
Event Description
|
Updated event description: a user facility clinical manager reported a patient who broke out in hives for an unspecified number of hemodialysis treatments occurring after (b)(6) 2018 and before (b)(6) 2018 while using fresenius optiflux 180nr dialyzers.
The clinic manager confirmed the patient had been administered 12.
5mg of benadryl intravenously prior to treatment, and remained on the machine to complete treatment, after which their symptoms resolved.
The clinic manager advised the patient had not missed any of their scheduled hemodialysis treatments due to the issue.
|
|
Manufacturer Narrative
|
The reported complaint was not confirmed as the complaint device was not returned for manufacturer evaluation.
A production records review was performed on the reported lot.
An investigation of the device history records (dhr) was conducted by the manufacturer.
There were two approved temporary deviation notices (dns) reported on the lot which were unrelated to the complaint event.
There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.
The lot met all release criteria.
A definitive conclusion regarding the complaint incident cannot be reached without physical examination of the actual device.
Therefore, the complaint is not confirmed.
|
|
Manufacturer Narrative
|
The plant investigation is in process.
A supplemental mdr will be submitted upon completion of this activity.
clinical investigation: the hemodialysis patient had a medical history of end stage renal disease (esrd).
Based on the available information, there is a likely causal association between the fresenius optiflux dialyzer and the patient¿s allergic reaction (characterized by hives during the hd treatment).
Although rare, hypersensitivity or anaphylactoid reactions to optiflux dialyzers are a known risk during hemodialysis.
There is no evidence of an optiflux dialyzer product deficiency or malfunction reported for this event.
|
|
Search Alerts/Recalls
|